CD47 is Required for Mesenchymal Progenitor Proliferation and Fracture Repair.

Area of Science:

• Biomedical Science
• Cell Biology
• Orthopedics

Background:

• CD47 is a cell-surface receptor involved in injury repair.
• Its role in bone healing remains uncharacterized.
• Disrupting CD47 can enhance tissue repair but may impact bone regeneration.

Approach:

• Investigated CD47's role in murine fracture models (closed and ischemic).
• Analyzed fracture callus using microcomputed tomography and histology.
• Assessed mesenchymal progenitor cell (MSC) proliferation and differentiation in vitro.
• Evaluated endothelial cell behavior in CD47-null models.
• Utilized CD47 morpholino in wild-type mice to confirm findings.

Key Points:

• CD47-null mice exhibited reduced bone callus volume and increased fibrous tissue post-fracture.
• CD47-null MSCs showed decreased colony formation and proliferation.
• Endothelial cells in CD47-null models displayed increased proliferation and vascularization.
• CD47 inhibition via morpholino mimicked knockout phenotypes, ruling out developmental artifacts.
• MSC dysfunction, not endothelial cell changes, primarily drove impaired healing.

Conclusions:

• CD47 inhibition impairs both non-ischemic and ischemic bone fracture healing.
• Reduced MSC proliferation is a key mechanism underlying impaired bone repair.
• Enhanced endothelial cell proliferation does not compensate for MSC dysfunction in CD47-disrupted bone healing.